$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Controlled release systems containing heparin and growth factors 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-013/00
  • A61F-002/00
  • A61K-009/14
출원번호 US-0206520 (1988-06-14)
발명자 / 주소
  • Edelman Elazer R. (Brookline MA) Langer Robert S. (Somerville MA) Klagsburn Michael (Newton MA) Mathiowitz Edith (Brookline MA)
출원인 / 주소
  • Massachusetts Institute of Technology (Cambridge MA 02)
인용정보 피인용 횟수 : 50  인용 특허 : 0

초록

A system for stabilizing fibroblast-derived growth factors, maintaining their bioactivity over a prolonged period of time and controllably releasing them for use is disclosed. The system uses growth factors bound to biocompatible substrates via heparin or heparin derived compounds to maintain the bi

대표청구항

A device for controlling the release rate of a fibroblast cross-linked dextran derived growth factor which comprises a substrate material having heparin or heparin sulfate bound thereto and the growth factor bound to the heparin or heparin sulfate.

이 특허를 인용한 특허 (50)

  1. Schroeder Jacqueline A. (Redwood City CA) Bentz Hanne (Newark CA) Estridge Trudy D. (Fremont CA), Affinity bound collagen matrices for the delivery of biologically active agents.
  2. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  3. Karandikar, Bhalchandra M.; Gibbins, Bruce L., Antimicrobial amorphous compositions.
  4. Karandikar, Bhalchandra M.; Gibbins, Bruce L.; Cornell, Ken A., Antimicrobial devices and compositions.
  5. Karandikar, Bhalchandra M.; Gibbins, Bruce L.; Cornell, Ken A., Antimicrobial silver compositions.
  6. Karandikar, Bhalchandra M.; Gibbins, Bruce L.; Cornell, Kenneth A., Antimicrobial silver compositions.
  7. McMaken, Jack D.; Gibbins, Bruce L., Antimicrobial site dressings.
  8. Iyer, Sriram S.; Kipshidze, Nicholas N.; Nikolaychik, Victor V., Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts.
  9. Iyer, Sriram S.; Kipshidze, Nicholas N.; Nikolaychik, Victor V., Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts.
  10. Iyer, Sriram S.; Kipshidze, Nicholas N.; Nikolaychik, Victor V., Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts.
  11. Athanasiou Kyriacos A. ; Boyan Barbara D., Biodegradable implant.
  12. Tuch Ronald J., Blood contacting medical device and method.
  13. Hunter, William L.; Machan, Lindsay S., Compositions and methods for treating or preventing diseases of body passageways.
  14. Athanasiou Kyriacos A ; Boyan Barbara D, Continuous release polymeric implant carrier.
  15. Sakiyama-Elbert, Shelly E.; Hubbell, Jeffrey A., Controlled release of non heparin-binding growth factors from heparin-containing matrices.
  16. Chen Yan,AUX ; Gray Bruce Nathaniel,AUX, Controlled release preparations for cytotoxic or cytostatic drugs.
  17. Gibbins, Bruce L.; Hopman, Lance D., Devices for delivering oxygen to the wounds.
  18. Fulmer, Mark Thomas; Armbruster, David A.; Frigg, Robert; Gruskin, Elliott A.; Kerr, Sean Hamilton, Drug-impregnated encasement.
  19. Fulmer, Mark Thomas; Armbruster, David A.; Frigg, Robert; Gruskin, Elliott A.; Kerr, Sean Hamilton, Drug-impregnated encasement.
  20. Hubbell Jeffrey A.,CHX ; Schense Jason,CHX, Enzyme-mediated modification of fibrin for tissue engineering.
  21. Hubbell,Jeffrey A.; Schense,Jason C.; Sakiyama,Shelly E., Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides.
  22. Hubbell, Jeffrey A.; Schense, Jason C.; Sakiyama, Shelly E., Enzyme-mediated modification of fibrin for tissue engineering: incorporation of proteins.
  23. Hubbell, Jeffrey A.; Schense, Jason, Enzyme-mediated modification of fivrin for tissue engineering.
  24. Armbruster, David; Dwyer, James; Chomyn, Jeffrey; Kerr, Sean, Films and methods of manufacture.
  25. Hubbell, Jeffrey A.; Schense, Jason C.; Sakiyama Elbert, Shelly E., Growth factor modified protein matrices for tissue engineering.
  26. Hubbell, Jeffrey A.; Schense, Jason C.; Sakiyama-Elbert, Shelly E., Growth factor modified protein matrices for tissue engineering.
  27. L?tolf,Matthias; Schense,Jason; Hubbell,Jeffrey A.; Jen,Anna, Growth factor modified protein matrices for tissue engineering.
  28. Jennings ; Jr. Robert N. ; Yang Bing ; Protter Andrew A. ; Wang Yu-Chang John, Hydrogel compositions for the controlled release administration of growth factors.
  29. Johnson Matthew S., Hypodermic needle for percutaneous drug delivery.
  30. Schense, Jason; Watson, John; Arrighi, Isabelle, Local treatment of bone defects.
  31. Radomsky Michael, Method of promoting bone growth with hyaluronic acid and growth factors.
  32. Radomsky Michael, Method of promoting bone growth with hyaluronic acid and growth factors.
  33. Radomsky, Michael, Method of promoting bone growth with hyaluronic acid and growth factors.
  34. Barritault Denis (Paris FRX) Jozefonvicz Jacqueline (Lamorlaye FRX) Tardieu Michele (Champigny sur Marne FRX) Slaoui Faouzi (Paris FRX) Caruelle Jean-Pierre (Saint Maur FRX) Courty Jose (Villecresnes, Method of regenerating cells and tissues using functionalized dextrans.
  35. Radomsky, Michael; Heidaran, Mohammad A., Method of treating diseased, injured or abnormal cartilage with hyaluronic acid and growth factors.
  36. Karandikar, Bhalchandra M.; Gibbins, Bruce L., Methods and compositions for metal nanoparticle treated surfaces.
  37. Maley, Joseph C.; Gibbins, Bruce L., Methods and compositions for treatment of dermal conditions.
  38. Ahola,Manja; Penttinen,Risto; S철derg책rd,Anders; Yli Urpo,Antti, Multilayered material bearing a biologically active agent and the preparation thereof.
  39. Habuchi Hiroko,JPX ; Suzuki Sakaru,JPX ; Kimata Koji,JPX, Oligosaccharide having affinity for fibroblast growth factor and process for producing same.
  40. Gibbins, Bruce L.; Hopman, Lance D., Oxygen-delivery closed cell foam matrix for wound treatment.
  41. Charier, Gaëlle; Müller-Maissen, Manuela; Jen, Anna, PDGF fusion proteins incorporated into fibrin foams.
  42. Lutolf, Matthias; Schense, Jason C.; Hubbell, Jeffrey A.; Jen, Anna, PTH containing cell growth matrix.
  43. Kausch, Annemie Rehor; Cerritelli, Simona, Polymeric tissue sealant.
  44. Rehor, Annemie; Cerritelli, Simona, Polymeric tissue sealant.
  45. Gibbins, Bruce L.; Hopman, Lance D., Silver-containing compositions, devices and methods for making.
  46. Gibbins, Bruce L.; Hopman, Lance D., Silver-containing compositions, devices and methods for making.
  47. Gibbins, Bruce L.; Hopman, Lance D., Silver-containing compositions, devices and methods for making.
  48. Gibbins, Bruce L.; Hopman, Lance D., Silver-containing compositions, devices, and methods for making.
  49. Schense, Jason; Watson, John; Arrighi, Isabelle, Supplemented matrices for the repair of bone fractures.
  50. Johnson Matthew S., Timed-release localized drug delivery by percutaneous administration.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로